(Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 35.85%-10.58M | -1,009.19%-12.19M | -814.70%-104.84M | -910.23%-12.24M | -2,898.84%-75M | -1,402.64%-16.5M | 83.48%-1.1M | 83.34%-11.46M | 86.47%-1.21M | 91.60%-2.5M |
Net income from continuing operations | -116.92%-396K | -28.45%-2.04M | 232.42%7.76M | 270.67%3.68M | 267.76%3.33M | 175.14%2.34M | 9.64%-1.59M | 9.16%-5.86M | 158.49%992K | -30.39%-1.98M |
Operating gains losses | --331K | --70K | -71.53%201K | -319.89%-387K | 496.04%1.6M | ---- | ---- | 253.00%706K | 36.43%176K | -645.95%-404K |
Depreciation and amortization | --44K | 133.33%14K | -4.17%23K | 66.67%10K | 16.67%7K | --0 | 0.00%6K | 1,100.00%24K | 200.00%6K | --6K |
Remuneration paid in stock | -23.36%292K | 89.36%89K | -20.39%738K | 58.97%124K | 66.07%186K | 41.11%381K | -89.94%47K | -26.89%927K | -44.68%78K | -50.00%112K |
Other non cashItems | 301.08%187K | -1,276.47%-234K | -161.00%-868K | -162.90%-217K | -301.87%-541K | -122.14%-93K | -104.36%-17K | 107.74%1.42M | 36.36%345K | 58.58%268K |
Change In working capital | 39.04%-11.04M | -2,342.89%-10.09M | -1,197.72%-112.69M | -450.05%-15.45M | -15,783.83%-79.58M | -6,158.53%-18.12M | 107.93%450K | 86.56%-8.68M | 63.94%-2.81M | 98.26%-501K |
-Change in receivables | ---41K | --13.82M | ---13.82M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Change in inventory | 28.54%-13.16M | ---20.63M | -873.31%-101.07M | -123.89%-6.43M | ---76.22M | ---18.42M | --0 | 83.41%-10.38M | 61.56%-2.87M | --0 |
-Change in prepaid assets | 989.67%2.01M | -1,263.09%-1.73M | -98.70%21K | 1,790.67%2.84M | -525.84%-3.15M | 18.71%184K | -91.80%149K | 182.53%1.62M | 153.57%150K | 43.10%-503K |
-Change in payables and accrued expense | 29.51%158K | -613.62%-1.55M | 2,615.00%2.17M | 2,354.02%1.96M | -10,700.00%-212K | -15.28%122K | 1,333.33%301K | 233.33%80K | -135.14%-87K | -98.48%2K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 35.85%-10.58M | -1,009.19%-12.19M | -814.70%-104.84M | -910.23%-12.24M | -2,898.84%-75M | -1,402.64%-16.5M | 83.48%-1.1M | 83.34%-11.46M | 86.47%-1.21M | 91.60%-2.5M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -121.32%-6.42M | -570.66%-5.14M | 271.20%45.24M | -98.72%146K | 809.13%15.73M | 2,096.55%30.13M | -239.96%-767K | 163.83%12.19M | 261.58%11.42M | 172,900.00%1.73M |
Net PPE purchase and sale | ---6.2M | ---5.38M | 96.54%-75K | 96.31%-75K | --0 | --0 | --0 | 84.22%-2.17M | -29.61%-2.03M | ---- |
Net investment purchase and sale | -101.16%-350K | --0 | 225.65%44.62M | --0 | 742.00%15.32M | 2,153.96%30.07M | -709.47%-769K | 354.95%13.7M | 344.38%13.44M | --1.82M |
Interest received (cash flow from investment activities) | 120.69%128K | 11,850.00%239K | 919.12%693K | 3,057.14%221K | 724.00%412K | 480.00%58K | 100.00%2K | 83.78%68K | 600.00%7K | 4,900.00%50K |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --587K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -121.32%-6.42M | -570.66%-5.14M | 271.20%45.24M | -98.72%146K | 809.13%15.73M | 2,096.55%30.13M | -239.96%-767K | 163.83%12.19M | 261.58%11.42M | 172,900.00%1.73M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -44.39%24.25M | 119.89%1.72M | 624.26%66.6M | 583.09%30.2M | -78.41%1.42M | 1,266.32%43.61M | -252.51%-8.63M | -89.19%9.2M | -146.00%-6.25M | -58.30%6.6M |
Net issuance payments of debt | ---17K | 99.85%-14K | -129.17%-9.61M | 99.80%-13K | --0 | --0 | -541.40%-9.6M | -133.78%-4.19M | -211,633.33%-6.35M | -100.11%-7K |
Net common stock issuance | ---- | ---- | 395.49%70.48M | 2,881,300.00%28.81M | --0 | ---- | ---- | -75.36%14.22M | -99.99%1K | 227.68%6.92M |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 208.62%6.01M | 53.05%1.73M | 1,050.10%5.9M | 393.64%1.4M | 553.21%1.42M | 16,133.33%1.95M | --1.13M | -96.69%513K | -37.94%283K | --218K |
Interest paid (cash flow from financing activities) | --0 | --0 | 87.61%-167K | --0 | --0 | --0 | 40.14%-167K | -131.62%-1.35M | 16.82%-183K | -250.65%-540K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -44.39%24.25M | 119.89%1.72M | 624.26%66.6M | 583.09%30.2M | -78.41%1.42M | 1,266.32%43.61M | -252.51%-8.63M | -89.19%9.2M | -146.00%-6.25M | -58.30%6.6M |
Net cash flow | ||||||||||
Beginning cash position | 42.19%5.41M | 47.49%21.1M | 226.25%14.31M | -74.76%2.61M | 1,270.32%62.06M | -3.47%3.81M | 226.25%14.31M | -39.22%4.39M | 51.71%10.35M | -78.19%4.53M |
Current changes in cash | -87.34%7.25M | -48.76%-15.62M | -29.49%7M | 357.76%18.1M | -1,093.29%-57.85M | 9,684.96%57.24M | -2,269.75%-10.5M | 450.78%9.92M | 262.25%3.95M | 141.77%5.82M |
Effect of exchange rate changes | -73.25%271K | -6,900.00%-70K | -20,200.00%-201K | 38,600.00%387K | -79,900.00%-1.6M | --1.01M | -150.00%-1K | 200.00%1K | 200.00%1K | 0.00%-2K |
End cash Position | -79.16%12.93M | 42.19%5.41M | 47.49%21.1M | 47.49%21.1M | -74.76%2.61M | 1,270.32%62.06M | -3.47%3.81M | 226.25%14.31M | 226.25%14.31M | 51.71%10.35M |
Free cash from | -1.73%-16.79M | -1,499.00%-17.57M | -669.64%-104.92M | -279.86%-12.32M | -2,740.95%-75M | -1,402.64%-16.5M | 83.48%-1.1M | 83.49%-13.63M | 69.19%-3.24M | 91.13%-2.64M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data